Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Apyx Medical Expects 2025 Revenues Of $47.6M-$49.5M Compared To Consensus Of $54.045M

Author: Benzinga Newsdesk | November 08, 2024 07:13am

The Company is introducing revenue guidance for the year ending December 31, 2025:

Total revenue in the range of $47.6 million to $49.5 million, representing growth of approximately 2% to 6% year-over-year, compared to $46.6 million the low-end of the updated total revenue guidance for the year ended December 31, 2024.
- Total revenue guidance assumes:
  - Advanced Energy revenue is expected to be in the range of $39.1 million to $41.0 million, representing growth of approximately 5% to 10% year-over-year, compared to approximately $37.2 million the low-end of the revenue guidance for Advanced Energy for the year ended December 31, 2024.
  - OEM revenue is expected to be approximately $8.5 million, representing a decrease of approximately 10% year-over-year, compared to the updated OEM revenue guidance of $9.4 million for the year ended December 31, 2024.
The Company also expects operating expenses of less than $40 million for the year ended December 31, 2025.

Posted In: APYX